⌘K

Login Start Free

Home/Filings/4/0001628280-24-028993

4//SEC Filing

Azelby Robert 4

Accession 0001628280-24-028993

CIK 0001771910other

View on SEC.gov Company Profile

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 9:45 PM ET

Size

4.8 KB

Accession

0001628280-24-028993

Insider Transaction Report

Form 4

Period: 2024-06-17

ADC Therapeutics SAADCT

Director

Transactions

Sale
Common Shares
2024-06-17$2.89/sh−6,995$20,216→ 53,005 total

Footnotes (1)

[F1]Represents Common Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units.

Documents

1 file

4
wk-form4_1718761526.xmlPrimary
FORM 4

Issuer

ADC Therapeutics SA

CIK 0001771910

Entity typeother

Related Parties

1

filerCIK 0001656998

Filing Metadata

Form type: 4
Filed: Jun 17, 8:00 PM ET
Accepted: Jun 18, 9:45 PM ET
Size: 4.8 KB

View on SEC.gov